Altimmune, Inc. (ALT) Social Stream



Altimmune, Inc. (ALT): $15.16

0.12 (+0.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

ALTIMMUNE INC (ALT) Price Targets From Analysts

Use the tables below to see what analysts covering ALTIMMUNE INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 6 $36 $25 $29.714 $14.03 111.79%
2022-01-10 6 $36 $25 $30.5 $14.03 117.39%
2022-01-31 6 $36 $21 $29.5 $14.03 110.26%
2022-05-17 5 $34 $21 $28.2 $14.03 101%
2022-06-01 5 $31 $21 $26.4 $14.03 88.17%
2022-08-03 4 $30 $21 $25.25 $14.03 79.97%
2022-08-12 4 $30 $25 $26.5 $14.03 88.88%
2022-08-17 4 $50 $25 $32.75 $14.03 133.43%
2022-08-31 4 $50 $25 $34 $14.03 142.34%
2022-10-02 5 $50 $25 $32.4 $14.03 130.93%
2022-11-21 6 $50 $25 $31.333 $14.03 123.33%
2023-01-20 7 $50 $20 $29.714 $14.03 111.79%

The Trend in the Analyst Price Target


Over the past 20 months, ALT's average price target has gone down $12.12.

ALT reports an average of 244.4% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-12 5 34 21 28.200 4.28 558.88%
2022-08-17 4 50 25 32.750 17.19 90.52%
2022-09-16 5 50 25 32.400 13.67 137.02%
2022-10-02 5 50 25 32.400 12.77 153.72%
2022-12-01 7 50 20 29.714 10.79 175.38%

ALT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


ALT's average broker recommendation rating improved by 0 over the prior 122 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ALT has a higher upside potential (average analyst target price relative to current price) than 1074.72% of all US stocks.
  • ALTIMMUNE INC's number of analysts covering the stock is higher than 353.43% of all US stocks.
  • In the context of stocks in the small market cap category, ALTIMMUNE INC's average analyst price target is higher than 993.57% of them.
  • ALTIMMUNE INC's variance in analysts' estimates is lower than -425.32% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, AVEO, ALBO, and HGEN are the three stocks most similar to ALTIMMUNE INC regarding the price target and analyst recommendation information presented here.

Is ALT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6599 seconds.